Skip to main content

827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma

Publication ,  Conference
Haykal, T; Beasley, G; Salama, A; Hanks, B
Published in: Regular and Young Investigator Award Abstracts
November 2022

Duke Scholars

Published In

Regular and Young Investigator Award Abstracts

DOI

Publication Date

November 2022

Start / End Page

A862 / A862

Publisher

BMJ Publishing Group Ltd

Conference Name

SITC 37th Annual Meeting (SITC 2022) Abstracts

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Haykal, T., Beasley, G., Salama, A., & Hanks, B. (2022). 827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma. In Regular and Young Investigator Award Abstracts (pp. A862–A862). BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2022-sitc2022.0827
Haykal, Tarek, Georgia Beasley, April Salama, and Brent Hanks. “827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma.” In Regular and Young Investigator Award Abstracts, A862–A862. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/jitc-2022-sitc2022.0827.
Haykal T, Beasley G, Salama A, Hanks B. 827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma. In: Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022. p. A862–A862.
Haykal, Tarek, et al. “827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2022, pp. A862–A862. Crossref, doi:10.1136/jitc-2022-sitc2022.0827.
Haykal T, Beasley G, Salama A, Hanks B. 827 The role of combination immune checkpoint inhibitors as salvage therapy for PD-1/PD-L1-resistant merkel cell carcinoma. Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd; 2022. p. A862–A862.

Published In

Regular and Young Investigator Award Abstracts

DOI

Publication Date

November 2022

Start / End Page

A862 / A862

Publisher

BMJ Publishing Group Ltd

Conference Name

SITC 37th Annual Meeting (SITC 2022) Abstracts

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology